Published in

American Association for the Advancement of Science, Science Advances, 41(6), 2020

DOI: 10.1126/sciadv.abc7031

Links

Tools

Export citation

Search in Google Scholar

Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Glycosylated “triple-interaction” stabilized siRNA nanomedicine ameliorated AD neuropathology by targeting BACE1.